<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To study the effect of operative region hypermethylation gene in human malignant <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic tumors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The abnormal methylation rate of P(15)(INK4B) gene 5'CpG island in 68 cases of malignant <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic tumor</z:e> samples were determined by methylation specific PCR using <z:chebi fb="0" ids="17137">bisulfite</z:chebi> modified DNA </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: The methylation rates of P(15)(INK4B) were 84%, 0, 50% and 75%, respectively, for 25 cases of <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>), 15 <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>), 16 <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) and 12 <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> (MM) </plain></SENT>
<SENT sid="3" pm="."><plain>P(15)(INK4B) gene was frequently methylated in patients with high risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and early stage of MM </plain></SENT>
<SENT sid="4" pm="."><plain>CONCLUSION: Hypermethylation of P(15)(INK4B) gene is one of the main causes of its inactivation </plain></SENT>
<SENT sid="5" pm="."><plain>Hypermethylation of CpG island was closely related to the development of malignant hematopoietic diseases </plain></SENT>
</text></document>